# Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes

> **NCT05206149** · PHASE4 · COMPLETED · sponsor: **A.O.U. Città della Salute e della Scienza** · enrollment: 10 (actual)

## Conditions studied

- Hypopituitarism

## Interventions

- **DRUG:** Intranasal glugagon
- **DRUG:** Intranasal placebo

## Key facts

- **NCT ID:** NCT05206149
- **Lead sponsor:** A.O.U. Città della Salute e della Scienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05206149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05206149, "Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05206149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*